NUCALA is an add-on, prescription maintenance treatment for patients 12 and older with severe eosinophilic asthma. NUCALA is not used to treat sudden breathing problems.
NUCALA is an add-on, prescription maintenance treatment for patients 12 and older with severe eosinophilic asthma. NUCALA is not used to treat sudden breathing problems.
How eosinophils can be a factor of your severe asthma and how NUCALA can help.
Talk to your doctor to see if adding NUCALA for your severe asthma is right for you.
NUCALA is an add-on, prescription maintenance treatment for patients 12 and older with severe eosinophilic asthma. NUCALA is not used to treat sudden breathing problems.
Do not use NUCALA if you are allergic to mepolizumab or any of the ingredients in NUCALA.
NUCALA is an add-on, prescription maintenance treatment for patients 12 and older with severe eosinophilic asthma. NUCALA is not used to treat sudden breathing problems.
Do not use NUCALA if you are allergic to mepolizumab or any of the ingredients in NUCALA.
Do not use to treat sudden breathing problems.
NUCALA can cause serious side effects, including:
Before receiving NUCALA, tell your healthcare provider about all of your medical conditions, including if you:
The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a burning feeling at the injection site), back pain, and weakness (fatigue).
You are encouraged to report negative side effects of prescription drugs to the FDA.Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Specialty Pharmacy Network for NUCALA (mepolizumab)
The specialty pharmacies listed below are currently participating in the specialty pharmacy network for NUCALA.
Which pharmacy is used may vary based on your health insurance plan.
Terms and Conditions
Co-pay Program Requirements:
To determine if you are eligible for the Co-pay Program for NUCALA, you and your healthcare provider must complete the enrollment form.
If you are eligible, the Co-pay Program for NUCALA may provide support for your cost share for NUCALA, up to a maximum amount of $11,000 annually. The Co-pay Program for NUCALA is not insurance. GSK reserves the right to rescind, revoke, or amend this program without notice.
You must have a prescription for NUCALA in order to apply for the Co-pay Program for NUCALA.
If you have insurance coverage provided through a state or federal government-funded medical or prescription drug program, including but not limited to Medicare, Medicaid, TRICARE, and Mi Salud, you are not eligible to participate in the Co-pay Program for NUCALA.
If you have prescription drug coverage that is provided by a commercial payer and the commercial payer has opted out of the Co-pay Program for NUCALA, you are not eligible to participate.
You must live in the United States (including the District of Columbia, Puerto Rico, and U.S. Virgin Islands).
You should inform program representatives of any changes in insurance coverage during the course of your enrollment in the Co-pay Program for NUCALA. Please note that after 90 days of non-use of an approved and/or activated Co-pay Card, funding will be released back into the program. If you are still receiving the product, you may contact the program and request that funds be reloaded onto the Co-pay Card.
Thank you for registering for MyNUCALA.
Be on the lookout for the information about NUCALA that will be headed your way shortly. If you have any questions, our nurses are standing by to help. Call 844‐4‐NUCALA (844-468-2252).